VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
LNC
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
LNCLincoln National Corporation
$36.58$7.0B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksLNCFinancials

Lincoln National Corporation (LNC) Financials

30Y historyFree accessUpdated daily

Operating margins remain highly unstable, as evidenced by the combined ratio swinging from a 3.2% low in 2023Q4 to a 120.1% peak in 2025Q1.

LNC Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Revenue18.88B18.21B17.99B11.71B18.93B17.61B17.58B17.25B16.42B14.26B13.33B13.57B13.59B11.96B11.54B10.64B10.41B8.5B9.22B10.47B8.96B5.47B5.37B5.28B4.64B6.38B6.85B6.8B6.09B4.9B4.73B
Revenue Growth %1.58%1.24%53.61%-38.13%7.52%0.15%1.88%5.1%15.16%6.95%-1.74%-0.18%13.61%3.71%8.4%2.17%22.54%-7.86%-11.94%16.88%63.69%1.93%1.65%13.98%-27.31%-6.85%0.64%11.77%24.26%3.48%-28.64%
Medical Costs & Claims12.38B7.77B13.39B11.66B16.5B13.71B14.12B13.15B11.72B9.82B9.51B9.83B9.28B8.08B7.74B7.31B7.28B8.09B8.7B8.28B6.96B4.31B4.24B4.14B4.54B4.27B5.88B6.1B5.27B4.77B4.14B
Medical Cost Ratio %65.56%42.66%74.45%99.57%87.14%77.85%80.32%76.21%71.4%68.91%71.37%72.45%68.27%67.55%67.13%68.67%69.85%95.22%94.31%79.05%77.66%78.78%78.85%78.37%97.87%66.95%85.81%89.66%86.62%97.4%87.56%
Gross Profit6.5B10.44B4.6B50M2.43B3.9B3.46B4.11B4.7B4.43B3.82B3.74B4.31B3.88B3.79B3.33B3.14B406M525M2.19B2B1.16B1.14B1.14B98.78M2.11B971.42M703.66M814.45M127.41M588.78M
Gross Margin %34.44%57.34%25.55%0.43%12.86%22.15%19.68%23.79%28.6%31.09%28.63%27.55%31.73%32.45%32.87%31.33%30.15%4.78%5.69%20.95%22.34%21.22%21.15%21.63%2.13%33.05%14.19%10.34%13.38%2.6%12.44%
Gross Profit Growth %-127.22%9092%-97.95%-37.59%12.75%-15.74%-12.59%5.93%16.17%2.11%-13.33%11.08%2.4%13.71%6.18%673.4%-22.67%-76.07%9.59%72.29%2.28%-0.57%1056.84%-95.31%117%38.05%-13.6%539.26%-78.36%-15.78%
Operating Expenses4.46B9.11B574M1.2B709M-743M3.04B3.19B2.81B3.3B2.36B2.31B2.31B2.25B2.22B2.83B2B927M662M320M224M87M100.46M95.1M-2.76B-2.14B-3.42B133.7M117.05M92.52M84.72M
OpEx / Revenue %23.63%49.99%3.19%10.23%3.75%-4.22%17.27%18.46%17.12%23.17%17.69%17.01%17.03%18.82%19.27%26.6%19.25%10.91%7.18%3.05%2.5%1.59%1.87%1.8%-59.6%-33.49%-49.91%1.97%1.92%1.89%1.79%
Depreciation & Amortization0096M44M65M50M37M26M9M4M4M4M4M4M4M4M4M-76M-76M-83M61M1M191.16M12.31M106.6M199.02M237.01M167.17M137.51M140.5M70.75M
Combined Ratio %89.19%92.65%77.64%109.8%90.89%73.63%97.59%94.67%88.52%92.07%89.06%89.46%85.31%86.37%86.41%95.27%89.1%106.13%101.49%82.11%80.16%80.37%80.72%80.17%38.27%33.46%35.9%91.62%88.54%99.29%89.35%
Operating Income2.04B1.34B4.02B-1.15B1.73B4.64B423M919M1.89B1.13B1.46B1.43B2B1.63B1.57B503M1.14B-521M-137M1.87B1.78B1.07B1.04B1.05B2.86B4.24B4.39B569.96M697.4M34.88M504.06M
Operating Margin %10.81%7.35%22.36%-9.8%9.11%26.37%2.41%5.33%11.48%7.93%10.94%10.54%14.69%13.63%13.59%4.73%10.9%-6.13%-1.49%17.89%19.84%19.63%19.28%19.83%61.73%66.54%64.1%8.38%11.46%0.71%10.65%
Operating Income Growth %--66.73%450.35%-166.55%-62.85%997.64%-53.97%-51.25%66.81%-22.5%1.96%-28.39%22.44%4.02%211.73%-55.68%317.85%-280.29%-107.31%5.4%65.4%3.8%-1.14%-63.39%-32.57%-3.3%670.06%-18.27%1899.36%-93.08%-19.55%
EBITDA2.28B1.56B4.12B-1.1B1.79B4.69B460M945M1.89B1.13B1.46B1.43B2B1.64B1.57B507M1.14B-597M-213M1.79B1.84B1.08B1.23B1.06B2.97B4.44B4.63B737.14M834.91M175.38M574.81M
EBITDA Margin %12.08%8.59%22.89%-9.43%9.46%26.66%2.62%5.48%11.54%7.95%10.97%10.57%14.72%13.67%13.63%4.76%10.94%-7.02%-2.31%17.1%20.52%19.65%22.84%20.06%64.03%69.66%67.56%10.83%13.72%3.58%12.14%
Interest Expense241M227M336M331M283M270M284M326M297M253M331M272M267M265M273M294M291M197M281M284M224M87M100.46M95.1M96.61M121.02M139.54M133.7M117.05M92.52M84.72M
Non-Operating Income-241M-227M-336M-331M-283M-270M-284M-326M-297M-253M-331M-272M-267M-265M-273M-294M-291M-197M-281M-284M-224M-87M-100.46M-95.1M2.77B4.12B4.25B-133.7M-117.05M-92.52M-84.72M
Pretax Income2.04B1.34B4.02B-1.15B1.73B4.64B423M919M1.89B1.13B1.46B1.43B2B1.63B1.57B503M1.14B-521M-137M1.87B1.78B1.07B1.04B1.05B1.62M705.91M800.2M569.96M697.4M34.88M504.06M
Pretax Margin %10.81%7.35%22.36%-9.8%9.11%26.37%2.41%5.33%11.48%7.93%10.94%10.54%14.69%13.63%13.59%4.73%10.9%-6.13%-1.49%17.89%19.84%19.63%19.28%19.83%0.04%11.07%11.69%8.38%11.46%0.71%10.65%
Income Tax315M161M747M-396M367M865M-76M33M244M-949M266M276M483M387M282M274M262M-106M-127M553M483M244M304.15M280.41M-89.97M144.71M214.9M109.61M187.62M12.65M147.67M
Effective Tax Rate %15.43%12.03%18.57%34.49%21.28%18.63%-17.97%3.59%12.94%-83.98%18.24%19.3%24.19%23.73%17.98%54.47%23.08%20.35%92.7%29.51%27.17%22.7%29.37%26.77%-5539.78%20.5%26.86%19.23%26.9%36.27%29.3%
Net Income1.73B1.18B3.27B-752M1.36B3.78B499M886M1.64B2.08B1.19B1.15B1.51B1.24B1.31B221M902M-485M57M1.22B1.32B831M707.01M511.94M91.59M545.6M585.3M460.35M509.77M933.99M513.56M
Net Margin %9.14%6.46%18.21%-6.42%7.17%21.46%2.84%5.13%10%14.58%8.94%8.51%11.15%10.4%11.38%2.08%8.66%-5.71%0.62%11.6%14.68%15.18%13.16%9.69%1.98%8.55%8.55%6.77%8.37%19.07%10.85%
Net Income Growth %29.58%-64.06%535.51%-155.38%-64.06%657.11%-43.68%-46.01%-21.07%74.41%3.29%-23.83%21.78%-5.26%494.12%-75.5%285.98%-950.88%-95.31%-7.67%58.36%17.54%38.1%458.94%-83.21%-6.78%27.14%-9.69%-45.42%81.87%6.51%
EPS (Diluted)8.795.8418.41-4.927.787.432.574.387.479.225.034.515.674.524.560.933.07-1.700.224.435.134.723.952.850.482.853.032.302.514.492.44
EPS Growth %25.71%-68.28%474.19%-163.24%4.71%189.11%-41.32%-41.37%-18.98%83.3%11.53%-20.46%25.44%-0.88%390.32%-69.71%280.59%-872.73%-95.03%-13.65%8.69%19.49%38.6%493.75%-83.16%-5.94%31.74%-8.37%-44.1%84.02%5.17%
EPS (Basic)-5.9518.66-4.927.9420.162.584.427.609.365.094.605.814.684.680.723.16-1.730.224.505.214.804.012.890.482.893.062.332.544.562.48
Diluted Shares Outstanding196.3M186.06M173.8M169.56M172.7M189.1M194.47M202.11M219.55M226.22M236.83M254.94M267.96M275.15M287.59M314.95M319.21M285.64M259.39M273.91M256.17M176.08M178.98M179.63M189.3M191.41M193.14M200.11M203.1M208.02M210.91M

Key Metrics

Growth RegimeMixed
ProfitabilityStrained
Balance SheetVulnerable
Cash FlowMixed
Top Statement Risk

Legacy reserve adequacy concerns

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Underwriting Volatility Impairs Operating Margins

As reported in recent financial statements, LNC's combined ratio has exhibited extreme volatility, swinging from a low of 3.2% in 2023Q4 to a peak of 120.1% in 2025Q1, highlighting significant instability in the company's core underwriting profitability and reliance on non-recurring accounting adjustments.

The erratic nature of the combined ratio suggests that LNC is struggling to maintain consistent underwriting discipline, likely due to frequent adjustments in actuarial assumptions. Investors should monitor whether these fluctuations represent genuine operational shifts or merely the ongoing impact of LDTI accounting and periodic reserve strengthening.

Revenue Growth Masking Underlying Instability

Based on reported figures, LNC achieved a 12.5% revenue growth in 2026Q1, yet this top-line expansion appears disconnected from bottom-line performance, as the company simultaneously reported a net loss of $172 million, suggesting that premium volume is not currently translating into sustainable shareholder value.

While the top-line growth trajectory appears positive on the surface, the inability to convert this revenue into positive net income warrants further investigation into the quality of the business being written. It is possible that the company is prioritizing volume over profitability to maintain market share, which may exacerbate long-term capital pressures.

Reserve Strengthening Clouds Earnings Visibility

According to recent SEC filings, the company's history of significant quarterly losses, such as the $722 million net loss in 2025Q1, indicates that legacy reserve strengthening remains a persistent drag on earnings, potentially masking the true underlying performance of the core insurance segments.

The recurring need to bolster reserves for legacy universal life products suggests that historical actuarial assumptions may have been overly optimistic. This pattern of reserve adjustments creates significant earnings noise, making it difficult for analysts to determine if the company has finally reached a point of reserve adequacy.

Capital Position Remains Under Scrutiny

As indicated by the reported net income volatility and the recent divestiture of the wealth management division, LNC's financial stability appears highly sensitive to capital-intensive legacy liabilities, which may continue to constrain management's ability to return capital to shareholders in the near term.

The divestiture of the wealth management business serves as a clear signal that management is prioritizing capital preservation over business diversification. Investors should remain cautious, as the company's ability to rebuild its regulatory capital cushion remains the primary determinant of its long-term operational viability.

LNC — Frequently Asked Questions

Quick answers to the most common questions about buying LNC stock.

What was Lincoln National Corporation's (LNC) revenue in 2025?

For fiscal year 2025, Lincoln National Corporation (LNC) reported total revenue of $18.21B. This represents a 284.7% increase compared to $4.73B in 1996.

Is Lincoln National Corporation (LNC) profitable?

Lincoln National Corporation (LNC) is profitable, generating $1.18B in net income for the fiscal year ending 2025 with a net profit margin of 6.5%.

What is Lincoln National Corporation's operating profit margin?

Lincoln National Corporation (LNC) reported an operating income of $1.34B, resulting in an operating profit margin of 7.3%. This margin reflects the operational efficiency of the business before interest and taxes.

What is Lincoln National Corporation's gross profit and gross margin?

Lincoln National Corporation (LNC) generated $10.44B in gross profit for the year, representing a gross profit margin of 57.3%. This demonstrates the company's core pricing power and production efficiency.